Skip to content
Nonprofiteer
← BIOCON INC

Form 990 for tax year 2023

Filed by BIOCON INC.

Totals

Total revenue
$3,848,762
Total expenses
$3,196,702
Contributions and grants received
$0
Grants paid
$0
Program service revenue
$3,848,762
Investment income
$0
Other revenue
$0
Total assets, end of year
$30,050,664
Total liabilities, end of year
$25,410,999
Net assets or fund balances, end of year
$4,639,665
Program services expenses (Part IX)
$3,196,702
Management and general expenses
$0
Fundraising expenses
$0
Program service expenses (Part III)
$3,196,702

Program services were 100.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 2a · Program service revenue: MAY ST MEDICAL -RENTAL INCOME

    total $2,426,963 · excluded $2,426,963

  • 2b · Program service revenue: JIII - RENTAL INCOME

    total $627,276 · excluded $627,276

  • 2c · Program service revenue: OLYPHANT - RENTAL INCOME

    total $509,103 · excluded $509,103

  • 2d · Program service revenue: JESSUP - RENTAL INCOME

    total $285,420 · excluded $285,420

Functional expenses

Part IX, the statement of functional expenses.

  • 13 · Office expenses

    total $2,457 · program services $2,457

  • 16 · Occupancy

    total $2,601,090 · program services $2,601,090

  • 22 · Depreciation, depletion and amortization

    total $592,263 · program services $592,263

  • 24a · Other expenses: BANK CHARGES

    total $892 · program services $892

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $327,272 · end of year $741,096

  • 9 · Prepaid expenses and deferred charges

    beginning of year $84,017 · end of year $188,892

  • 10a · Land, buildings and equipment: cost or other basis

    $35,970,589

  • 10b · Land, buildings and equipment: accumulated depreciation

    $10,306,568

  • 10c · Land, buildings and equipment, net

    beginning of year $13,095,977 · end of year $25,664,021

  • 15 · Other assets

    beginning of year $3,464,710 · end of year $3,456,655

  • 17 · Accounts payable and accrued expenses

    beginning of year $42,521 · end of year $87,955

  • 23 · Secured mortgages and notes payable

    beginning of year $4,570,352 · end of year $14,265,494

  • 25 · Other liabilities

    beginning of year $8,371,498 · end of year $11,057,550

  • 27 · Net assets without donor restrictions

    beginning of year $3,987,605 · end of year $4,639,665

Mission and programs · 2023

Mission

BIOCON, INC. (BIO) WAS FORMED TO SERVE AS THE SOLE VOTING MEMBER OF, AND ACT AS THE HOLDING COMPANY FOR, THE MUSCULOSKELETAL TRANSPLANT FOUNDATION INC., (MTF) A NON-PROFIT 501(C) ORGANIZATION AND DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH, (DIZG) A GERMAN NON-PROFIT ORGANIZATION (AS DISCLOSED ON FORM 5471). MTF'S MISSION IS TO PROVIDE QUALITY ALLOGRAFT TISSUES FOR TRANSPLANTATION, RESEARCH AND EDUCATION. DIZG SPECIALIZES IN CULTURING AND DISTRIBUTION OF KERATINOCYTES, MUSCULOSKELETAL, AND OTHER TISSUE FORMS. BIO, AS HOLDING COMPANY, HAS AUTHORITY TO APPROVE FUNDAMENTAL AMENDMENTS TO ORGANIZATIONAL DOCUMENTS AND TO APPROVE CERTAIN CORPORATE TRANSACTIONS SUCH AS MERGERS AND DISSOLUTIONS. BIO ALSO HAS THE EXCLUSIVE RIGHT TO ELECT OR APPOINT ALL MEMBERS OF THE BOARD OF DIRECTORS OF MTF AND DIZG. BIO CONTINUES TO MONITOR AND GUIDE THE ACTIVITIES OF MTF AND DIZG, AS WELL AS ANY AFFILIATES THAT MAY BE FORMED OR ACQUIRED IN THE FUTURE, TO FOSTER THE PROVISION OF HIGH QUALITY HUMAN ALLOG

Activities or mission (Part I)

BIOCON, INC'S. (BIO) MISSION IS TO SUPPORT THE TAX-EXEMPT MISSION OF THE MUSCULOSKELETAL TRANSPLANT FOUNDATION INC., (MTF). CONTINUED ON SCHEDULE O.

  • SEE SCHEDULE O.

    Expenses $3,196,702

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Joseph A Yaccarino

    PRESIDENT/CE

    Total calculated
    $914,560
    From this org
    $0
    From related orgs
    $863,875
    Other
    $50,685

    Schedule J breakdown matched by us

    Base
    not reported + $659,467 related
    Bonus
    not reported + $191,580 related
    Other
    not reported + $12,828 related
    Deferred
    not reported + $19,800 related
    Nontaxable benefits
    not reported + $33,930 related
    Filer's total
    not reported + $914,560 related
  • Michael J Kawas

    TREASURER/CF

    Total calculated
    $707,128
    From this org
    $0
    From related orgs
    $673,909
    Other
    $33,219

    Schedule J breakdown matched by us

    Base
    not reported + $545,316 related
    Bonus
    not reported + $120,820 related
    Other
    not reported + $7,773 related
    Deferred
    not reported + $19,800 related
    Nontaxable benefits
    not reported + $16,464 related
    Filer's total
    not reported + $707,128 related
  • Jennifer Birmingham

    SECRETARY/GE

    Total calculated
    $538,363
    From this org
    $0
    From related orgs
    $487,128
    Other
    $51,235

    Schedule J breakdown matched by us

    Base
    not reported + $395,200 related
    Bonus
    not reported + $90,410 related
    Other
    not reported + $1,518 related
    Deferred
    not reported + $19,800 related
    Nontaxable benefits
    not reported + $34,480 related
    Filer's total
    not reported + $538,363 related
  • William W Tomford MD

    DIRECTOR

    Total calculated
    $75,000
    From this org
    $0
    From related orgs
    $75,000
    Other
    $0
  • Donald Hackbarth MD

    DIRECTOR

    Total calculated
    $35,000
    From this org
    $0
    From related orgs
    $35,000
    Other
    $0
  • Joseph Zuckerman MD

    DIRECTOR

    Total calculated
    $30,000
    From this org
    $0
    From related orgs
    $30,000
    Other
    $0
  • Symeria T Hudson

    DIRECTOR

    Total calculated
    $28,750
    From this org
    $0
    From related orgs
    $28,750
    Other
    $0
  • Joseph A Buckwalter MD

    DIRECTOR

    Total calculated
    $27,500
    From this org
    $0
    From related orgs
    $27,500
    Other
    $0
  • Sharon Gabrielson

    DIRECTOR

    Total calculated
    $25,000
    From this org
    $0
    From related orgs
    $25,000
    Other
    $0
  • Allan Gross MD

    NON-VOTING D

    Total calculated
    $0
  • Gerald Finerman MD

    NON-VOTING D

    Total calculated
    $0

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

None.

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

SCHEDULE J, PAGE 1, PART I, LINE 3
BIOCON, INC., (BIO), IS THE SOLE CORPORATE MEMBER OF THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC., (MTF). THE BOARD OF DIRECTORS AND THE OFFICERS OF BIO OVERLAPS THAT OF MTF WITH BIO HAVING THE EXCLUSIVE RIGHT TO ELECT OR APPOINT ALL MEMBERS OF THE BOARD OF DIRECTORS OF MTF. BELOW IS AN OUTLINE OF MTF'S PROCESS TO ESTABLISH COMPENSATION LEVELS FOR EXECUTIVE AND OFFICER COMPENSATION. EACH YEAR, MTF RECEIVES AND ASSESSES THE REASONABLENESS OF TOTAL COMPENSATION ARRANGEMENTS FOR THE EXECUTIVE TEAM, INCLUDING THE CEO. THE ANALYSIS INCORPORATES COMPENSATION SURVEY DATA, LAST COMPILED IN JULY 2023, FORM 990'S OF COMPANIES OF RELATED INDUSTRIES AND SIMILAR SIZE. A BLEND OF BOTH FOR-PROFIT AND NOT-FOR-PROFIT COMPANIES IS USED. EVERY THIRD YEAR (MOST RECENTLY JULY 2023), MTF RETAINS THE SERVICES OF AN INDEPENDENT COMPENSATION CONSULTANT TO ASCERTAIN AND DETERMINE THAT MTF IS PAYING AND PROVIDING A REASONABLE TOTAL COMPENSATION PACKAGE TO THEIR EXECUTIVES AND TO PROVIDE AN OPINION LETTER OF THEIR FINDINGS. COMPENSATION COMMITTEE REVIEW: MTF'S BOARD OF DIRECTORS ESTABLISHED A COMPENSATION COMMITTEE IN 1995. THE RESPONSIBILITY OF THE COMMITTEE INCLUDES THE REVIEW AND APPROVAL OF EXECUTIVE AND STAFF COMPENSATION AND BENEFITS. THE COMPENSATION COMMITTEE TYPICALLY MEETS SEMI-ANNUALLY TO REVIEW MERIT AND BONUS RECOMMENDATIONS. A COPY OF THE COMPENSATION COMMITTEE'S CHARTER, AGENDAS, MEETING MATERIALS, AND MEETING MINUTES ARE MAINTAINED.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

No itemized grants to organizations on this return.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • MUSCULOSKELETAL TRANSPLANT FOUNDATION INC

    501C3 · TISSUE BK. · DC · controlled entity

    Directly controlled by BIOCON

  • DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH

    SEE PT VII · GM · controlled entity

    Directly controlled by BIOCON

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Disregarded entities

Part I: entities that legally are the filer and file no return of their own.

  • MAY STREET MEDICAL LLC

    SEE PT VII · DE · income $2,426,963 · assets $10,602,573

    Directly controlled by BIOCON

  • OLYPHANT LLC

    SEE PT VII · DE · income $509,103 · assets $3,226,818

    Directly controlled by BIOCON

  • JESSUPPRTB LLC

    SEE PT VII · PA · income $285,420 · assets $2,175,005

    Directly controlled by BIOCON

  • JESSUP III LLC

    SEE PT VII · PA · income $627,276 · assets $14,035,922

    Directly controlled by BIOCON

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • DEUTSCHES INSTITUT FUR ZELL-UND GEWEBEERSATZ GMBH

    C CORP · SEE PT VII · GM

    Directly controlled by BIOCON

Provenance

Return type
form_990
Tax year
2023
Filed
15 November 2024
IRS schema version
2023v5.0
Source object
202433209349313818

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.